Skip to content

ContaCT alerts came sooner than usual care in a test on past scans

In a retrospective test that FDA reviewed, Viz.ai ContaCT sent its stroke alert in 7.32 minutes on average, against 58.72 minutes for usual-care notification of the specialist.

Benefit status
Intended Read outcome assessment
Evidence
Found by a court or regulator
Source published
Sources
1 publication

Benefits

Benefit

A mean difference of 51.40 minutes

Awaiting review

Outcome identifiers

Unresolved

Not reviewedUnresolved

Category

Reduced Task Time

Awaiting review

Status

Intended. The faster alerts were computed in a retrospective test on past scans, so the alerts did not reach specialists or change care, and the faster notification is expected in use. [1]

Fully reviewed: supporting details for Status

Review date: 29 October 2026.

Sources: [1]

Beneficiary groups

Organizations.

Awaiting review

Beneficiaries

Unresolved

Not reviewedUnresolved

Reach

Unresolved

Not reviewedUnresolved

Distribution and access

Unresolved

Not reviewedUnresolved

Duration

Unresolved

Not reviewedUnresolved

Expected?

Yes

Awaiting review

Costs and harms

Unresolved

Not reviewedUnresolved

AI system

System

ContaCT

Awaiting review

Model

This is an explicit unresolved assignment: the sources on record do not settle this question.

Not reviewedUnresolved

Release

Unresolved

Not reviewedUnresolved

Provider

Unresolved

Not reviewedUnresolved

Role

Unresolved

Not reviewedUnresolved

Configuration

Unresolved

Not reviewedUnresolved

Inputs and outputs

Unresolved

Not reviewedUnresolved

Autonomy

Unresolved

Not reviewedUnresolved

Workflow

The software analyzed head and neck CT angiograms acquired during a stroke protocol. Alerts went straight to the specialist through a mobile application.

Awaiting review

Human oversight

Unresolved

Not reviewedUnresolved

Relation to AI

FDA reviewers compared the alert time of the software with the recorded usual-care alert time on the same 44 cases, a paired comparison with and without the software.

Awaiting review

AI contribution

FDA reviewers compared the alert time of the software with the recorded usual-care alert time on the same 44 cases, a paired comparison with and without the software.

Awaiting review

Measurement

Studies

Controlled observational. [1]

Fully reviewed: supporting details for Studies

Review date: 29 October 2026.

Sources: [1]

Study design

Controlled observational. [1]

Fully reviewed: supporting details for Study design

Review date: 29 October 2026.

Sources: [1]

Measurement

Retrospective standalone test on archived CT angiograms; device alert times compared with usual-care notification times from radiology reports. [1]

Fully reviewed: supporting details for Measurement

Review date: 29 October 2026.

Sources: [1]

Setting and sample

300 archived CT angiograms; 44 true positive cases with usual-care times. [1]

Fully reviewed: supporting details for Setting and sample

Review date: 29 October 2026.

Sources: [1]

Measures

Time from CT angiogram to specialist notification. [1]

Fully reviewed: supporting details for Measures

Review date: 29 October 2026.

Sources: [1]

Comparison

Usual-care notification time recorded in radiology reports. [1]

Fully reviewed: supporting details for Comparison

Review date: 29 October 2026.

Sources: [1]

Results

Mean 7.32 minutes against 58.72 minutes; mean difference 51.40 minutes. [1]

Fully reviewed: supporting details for Results

Review date: 29 October 2026.

Sources: [1]

Additional value from AI

Mean 51.40 minutes earlier alert. [1]

Fully reviewed: supporting details for Additional value from AI

Review date: 29 October 2026.

Sources: [1]

Limitations

Time comparison limited to the subset with usual-care times; archived scans; no patient outcomes. [1]

Fully reviewed: supporting details for Limitations

Review date: 29 October 2026.

Sources: [1]

Denominators

One analysis per scan. [1]

Fully reviewed: supporting details for Denominators

Review date: 29 October 2026.

Sources: [1]

Materials for replication

None public. [1]

Fully reviewed: supporting details for Materials for replication

Review date: 29 October 2026.

Sources: [1]

Money

Kind of value

The kind of monetary value is unclear.

Not reviewedUnresolved

Amount

The monetary value is not established.

Not reviewedUnresolved

Currency and prices

The currency and price basis are unclear.

Not reviewedUnresolved

Period and unit

The period and unit of the monetary estimate are unclear.

Not reviewedUnresolved

Realization

Whether the monetary value was realized is unclear.

Not reviewedUnresolved

Recipients and payers

The recipients and payers are unclear.

Not reviewedUnresolved

Gross or net

Whether the monetary figure includes costs is unclear.

Not reviewedUnresolved

Included costs

The costs included in the estimate are unclear.

Not reviewedUnresolved

Comparison

The financial comparison is not established.

Not reviewedUnresolved

Method

The method used to calculate monetary value is unclear.

Not reviewedUnresolved

Return and payback

The return on investment or payback period is not established.

Not reviewedUnresolved

People and places

Participants

Developer: Viz.ai, Inc. Operator: Viz.ai (standalone performance test on archived CT angiograms).

Awaiting review

Jurisdictions

Benefit: Two clinical sites, United States. Developer: United States. Operator: United States.

Awaiting review

Ownership and control

Unresolved

Not reviewedUnresolved

Dependencies

Unresolved

Not reviewedUnresolved

Cross-border connections

Unresolved

Not reviewedUnresolved

Geopolitical implications

The geopolitical implications are unclear.

Not reviewedUnresolved

Follow-up

Conditions for replication

Scans meet the acquisition parameters in the labeling. The hospital network has a specialist ready to act on alerts. Usual radiology review continues in parallel.

Awaiting review

Replication attempts

Unresolved

Not reviewedUnresolved

Later findings

Unresolved

Not reviewedUnresolved

Availability

Unresolved

Not reviewedUnresolved

Institutional decision

A relevant institutional decision has not been established.

Not reviewedUnresolved

Grounds

The grounds for an institutional decision are unclear.

Not reviewedUnresolved

Action and result

The result of an institutional decision is not established.

Not reviewedUnresolved

Success criterion

The criterion for a successful institutional decision is unclear.

Not reviewedUnresolved

Evidence

Source numbers

AIBD-0622-source-0001

Awaiting review

Citations

Numbered references below.

Awaiting review

Language

Unresolved

Not reviewedUnresolved

Source relationships

Independent

Awaiting review

Original evidence

Unresolved

Not reviewedUnresolved

Access and versions

Unresolved

Not reviewedUnresolved

Supported findings

Unresolved

Not reviewedUnresolved

Evidence strength

Found by a regulator. Sources: one independent regulatory document. The cited evidence includes no independent study or report. [1]

Fully reviewed: supporting details for Evidence strength

Review date: 29 October 2026.

Sources: [1]

Missing evidence

Unresolved

Not reviewedUnresolved

Grades

Assessed benefits

Organizations.

Awaiting review

Depth

The revised record no longer states this information.

Not reviewedUnresolved: supporting details for Depth

The record revision removed the mapped value.

Reasons

Organizations: The 51-minute difference comes from a retrospective test on past scans in which no alert reached a specialist, so no realized gain for the sites is reported.

Awaiting review

Observed or intended

Intended. The faster alerts were computed in a retrospective test on past scans, so the alerts did not reach specialists or change care, and the faster notification is expected in use. [1]

Fully reviewed: supporting details for Observed or intended

Review date: 29 October 2026.

Sources: [1]

Rubric

Unresolved

Not reviewedUnresolved

Assessor and date

Unresolved

Not reviewedUnresolved

Alternative assessments

Unresolved

Not reviewedUnresolved

Fill

Found by a regulator

Awaiting review

Entry details

Kind

The case describes an evaluation or a study. A regulatory review of a standalone performance test. [1]

Fully reviewed: supporting details for Kind

Review date: 29 October 2026.

Sources: [1]

Field

Healthcare.

Awaiting review

Purpose

ContaCT was built to alert a stroke specialist to a suspected large vessel occlusion in parallel with the usual radiology read. Faster alerts are that purpose.

Awaiting review

Dates

Source published: 13 February 2018. Updated: 29 October 2026.

Awaiting review

Stage

The system was tested in a laboratory. A retrospective standalone test on past scans before authorization; the alerts did not reach a treating team. [1]

Fully reviewed: supporting details for Stage

Review date: 29 October 2026.

Sources: [1]

Version

SHA-256: c1211c7bea95…

Awaiting review: supporting details for Version

SHA-256 of the public case, its assessments, and its displayed answers and notes, excluding its own identifier and the derived coverage summary.

References

Other identifiers

Unresolved

Not reviewedUnresolved

Category mappings

Unresolved

Not reviewedUnresolved

Citable summary

Unresolved

Not reviewedUnresolved

Revisions

2 revisions. Latest: 29 October 2026.

Awaiting review

Sources

  1. Regulatory document Independent author

    U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo classification request for ContaCT (DEN170073): decision summary. Granted 2018-02-13.

Cite this case

BibTeX Download BibTeX

Version c1211c7bea95, archived in the edition of 29 October 2026

Benefit marks

Depth

The number and color show the depth of a benefit.

  1. Depth 1. A convenience, or time or money saved.
  2. Depth 2. A measurable improvement in a result or ability.
  3. Depth 3. A lasting change, an ability restored, or a risk removed.
  4. Depth 4. A serious harm averted or a serious condition resolved in time.
  5. Depth 5. A life or livelihood preserved, or a change documented across a population.

Beneficiary

  • Circle: a person
  • Square: an organization
  • Triangle: society

Evidence

  • Solid. A court or regulator found a benefit, or researchers independently studied it.

  • Hatched. Independent reporting.

  • Outline. Claimed by the parties. Only the people or organizations involved, or sources whose independence has not been assessed, support the benefit.

The fill changes with the evidence. The depth color stays the same.

How benefits are assessed